These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18498710)

  • 1. Protective effect of the endothelin antagonist CPU0213 against isoprenaline-induced heart failure by suppressing abnormal expression of leptin, calcineurin and SERCA2a in rats.
    Xu M; Ji H; Dai DZ; Tang XY; Dai Y
    J Pharm Pharmacol; 2008 Jun; 60(6):739-45. PubMed ID: 18498710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin receptor antagonist CPU0213 and vitamin E reverse downregulation of FKBP12.6 and SERCA2a: a role of hyperphosphorylation of PKCepsilon.
    Li N; Jia N; Dai DZ; Dai Y
    Eur J Pharmacol; 2008 Sep; 591(1-3):211-8. PubMed ID: 18611397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress-induced cardiac insufficiency relating to abnormal leptin and FKBP12.6 is ameliorated by CPU0213, an endothelin receptor antagonist, which is not affected by the CYP3A suppressing effect of erythromycin.
    Cheng YS; Dai DZ; Dai Y
    J Pharm Pharmacol; 2009 May; 61(5):569-76. PubMed ID: 19405994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of isoproterenol-induced downregulation of phospholamban and FKBP12.6 by CPU0213-mediated antagonism of endothelin receptors.
    Feng Y; Tang XY; Dai DZ; Dai Y
    Acta Pharmacol Sin; 2007 Nov; 28(11):1746-54. PubMed ID: 17959025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the endothelin receptor antagonist CPU0213, and its modulation by rifampin, on cardiac and vascular tissue following chronic isoproterenol treatment.
    Luo L; Dai DZ; Dai Y
    Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):757-65. PubMed ID: 18215179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testis dysfunction by isoproterenol is mediated by upregulating endothelin receptor A, leptin and protein kinase Cvarepsilon and is attenuated by an endothelin receptor antagonist CPU0213.
    Cheng YS; Dai DZ; Dai Y
    Reprod Toxicol; 2010 Jul; 29(4):421-6. PubMed ID: 20307649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endothelin in the effects of isoprenaline on potassium currents and calsequestrin 2 expression in the heart.
    Li N; Jia N; Dai DZ; Hu C; Dai Y
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):557-63. PubMed ID: 20529095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endothelin receptor antagonist CPU0213 is more effective than aminoguanidine to attenuate isoproterenol-induced vascular abnormality by suppressing overexpression of NADPH oxidase [correction of oxidas], ETA, ETB, and MMP9 in the vasculature.
    Xu J; Li N; Dai DZ; Yu F; Dai Y
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):42-8. PubMed ID: 18594475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of FKBP12.6 and SERCA2a contributes to acute heart failure in septic shock and is related to an up-regulated endothelin signalling pathway.
    He HB; Yu F; Dai DZ; Dai Y
    J Pharm Pharmacol; 2007 Jul; 59(7):977-84. PubMed ID: 17637193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effects of hydroxysafflor yellow A on diabetic cardiac insufficiency attributed to up-regulation of the expression of intracellular calcium handling proteins of sarcoplasmic reticulum in rats.
    He H; Liu Q; Shi M; Zeng X; Yang J; Wu L; Li L
    Phytother Res; 2008 Aug; 22(8):1107-14. PubMed ID: 18570267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalizing NADPH oxidase contributes to attenuating diabetic nephropathy by the dual endothelin receptor antagonist CPU0213 in rats.
    Xu M; Dai DZ; Dai Y
    Am J Nephrol; 2009; 29(3):252-6. PubMed ID: 18802327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU86017.
    Na T; Dai DZ; Tang XY; Dai Y
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):39-49. PubMed ID: 17287947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CPU0213, a novel endothelin receptor antagonist, ameliorates septic renal lesion by suppressing ET system and NF-kappaB in rats.
    He HB; Dai DZ; Dai Y
    Acta Pharmacol Sin; 2006 Sep; 27(9):1213-21. PubMed ID: 16923343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
    Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercholesterolaemia induces early renal lesions characterized by upregulation of MMP-9 and iNOS and ET(A)R: alleviated by a dual endothelin receptor antagonist CPU0213 and simvastatin.
    Luo L; Zheng YF; Dai Y; Dai DZ
    J Pharm Pharmacol; 2009 Jun; 61(6):775-80. PubMed ID: 19505368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total triterpene acids, active ingredients from Fructus Corni, attenuate diabetic cardiomyopathy by normalizing ET pathway and expression of FKBP12.6 and SERCA2a in streptozotocin-rats.
    Qi MY; Liu HR; Dai DZ; Li N; Dai Y
    J Pharm Pharmacol; 2008 Dec; 60(12):1687-94. PubMed ID: 19000375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil improves diabetic vascular activity through suppressing endothelin receptor A, iNOS and NADPH oxidase which is comparable with the endothelin receptor antagonist CPU0213 in STZ-injected rats.
    Luo L; Dai DZ; Cheng YS; Zhang Q; Yuan WJ; Dai Y
    J Pharm Pharmacol; 2011 Jul; 63(7):943-51. PubMed ID: 21635260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in cardiac function after sarcoplasmic reticulum Ca2+-ATPase gene transfer in a beagle heart failure model.
    Mi YF; Li XY; Tang LJ; Lu XC; Fu ZQ; Ye WH
    Chin Med J (Engl); 2009 Jun; 122(12):1423-8. PubMed ID: 19567165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel endothelin receptor antagonist CPU0213 improves diabetic cardiac insufficiency attributed to up-regulation of the expression of FKBP12.6, SERCA2a, and PLB in rats.
    Qi MY; Xia HJ; Dai DZ; Dai Y
    J Cardiovasc Pharmacol; 2006 Jun; 47(6):729-35. PubMed ID: 16810072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoproterenol disperses distribution of NADPH oxidase, MMP-9, and pPKCepsilon in the heart, which are mitigated by endothelin receptor antagonist CPU0213.
    Cheng YS; Dai DZ; Dai Y
    Acta Pharmacol Sin; 2009 Aug; 30(8):1099-106. PubMed ID: 19597524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.